Anthropic partners with pharma firms to cut document review by 89%

At Generate Biomedicines, scientists used Claude Code to shorten a CAR T-cell therapy component by 70%, resulting in immune cells that produced roughly ten times more cancer-detecting receptors. Divergence Labs used Claude to generate 35,000 antibody designs for a food-allergy treatment in one month, identifying candidates that outperformed standard medication in initial tests. BigHat Biosciences combined Claude with automated labs to test 1,010 antibody variations, creating versions that bound targets more than 10 times tighter and aggregated 100 times more slowly.

In administrative tasks, Enveda used Claude to review 1,061 pages of manufacturing documentation, reducing manual checking time by 89% from over 25 hours to under three. The system found all 11 issues previously identified by humans plus seven new ones. Anthropic also partnered with Bristol Myers Squibb to assess clinical study plans, with executives noting the tool generated initial analyses in minutes that would otherwise take days.